Skip to content

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at its Clinical Services Centre of Excellence in Rhymney, UK.

Following a successful inspection by the MHRA, Sharp can now offer a range of clinical trial and commercial services from the £9.5 million facility including primary and secondary packaging with low humidity control, labelling, storage and distribution, QP services as well as controlled drug storage.

The Centre also enables Sharp to offer a broader range of integrated services including serialization and Interactive Response Technology (IRT) solutions for clinical trial management.

Frank Lis, president of Sharp Clinical Services, said:

“The Clinical Services Centre of Excellence in Rhymney has tripled Sharp’s clinical service capacity for the pharmaceutical, biotech and clinical research sectors.

“With the integrated capabilities on offer, the facility also better enables us to offer full-service support and meet the increased global demand for Phase III clinical trials and commercial pharmaceutical services. We are dedicated to supporting our customers for years to come and the Rhymney site is a sign of that commitment.”

The MHRA approval comes as Sharp celebrates its 30th year of clinical operations in the UK.

Lis added:

“To be able to celebrate two such significant achievements at the same time is testament to the effort and dedication of everyone involved in the success of Sharp.”

Sharp has also invested in a solar panel system at the site that will generate approximately 20% of Sharp Clinical Services’ total annual electricity requirements, further reducing the company’s carbon footprint and increasing environmental performance.

About Sharp

Sharp, part of UDG healthcare, is a global leader in contract packaging and clinical services. Operating from eight state-of-the-art facilities across the US and Europe, Sharp has built an international reputation for delivering cost-effective blister packaging, bottling, secondary assembly and labelling of injectable presentations, compliance packaging, formulation and manufacturing services, label design and printing. We are also a world leader in ’Track and Trace’ and serialization services, with over eleven years’ experience in implementing serialized solutions for our pharma clients.

Sharp Clinical

Sharp Clinical offers a full complement of clinical trial services, including analytical, formulation development, clinical manufacturing and packaging, storage and distribution. Sharp also offers an interactive response technology (IRT) platform which can accommodate simple to complex randomization schemes as well as clinical supply chain management.

During 2018, Sharp Clinical invested $36 million in new dedicated facilities in both the US and the UK and can offer QP services for European distribution. We service every phase of the drug lifecycle from Phase 1 through to commercialization and through our global network of over 30 depots we can distribute to every region of the world. Our highly experienced team will help you optimize every aspect of your clinical trial.

For more information on Sharp and its solutions, visit or follow us on LinkedIn, and Twitter.

Sharp contact
Alison Dillon
Marketing Communications Manager
Tel: +353-87-146-8522

Related Resources

NEXT WEEK: Sharp & the @AlliancetoZero present a webinar on #sustainability in the #pharma industry. Join industry experts to learn more about how companies are working together to build a sustainable pharma supply chain.

Register here:

Join the Alliance to Zero on December 8th for a webinar on developing a #netzero emissions drug delivery device.

In the spirit of the holiday, our colleagues in Bethlehem, PA came together to create Thanksgiving-themed works of art. Happy Thanksgiving from the Sharp family to yours!

#thanksgiving #love #health #growth #strength